GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pathfinder Cell Therapy PFND · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 30 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Pathfinder Cell Therapy — daily PFND Delayed
Market value
$66,716
Last close × shares
Volume
500
Shares, 30 Oct 2026

About Pathfinder Cell Therapy

Its shares trade under the ticker PFND. It has been listed since 22 September 1992.

Pathfinder Cell Therapy, Inc. is a development stage regenerative medicine company. The company is headquartered in Cambridge, Massachusetts. The firm is seeking to develop cell-based and related therapies for the treatment of a range of diseases and medical conditions characterized by organ-specific cell damage. The firm is engaged in developing cell-based therapy for the treatment of diabetes, renal disease, myocardial infarction and other diseases characterized by organ-specific cell damage. The firm has discovered a mammalian cell type, which is able to stimulate damaged tissues to regenerate without the Pathfinder Cells (PCs) themselves being incorporated into the new tissue. PCs have shown efficacy in approximately three different animal models of diabetes, cardiac ischemia and renal reperfusion injury. The firm has tested these models for PCs from both rat and human sources. As of September 30, 2015, the Company had no revenue generated.

Figures and description from our data supplier, not checked against the company's own report.

More about Pathfinder Cell Therapy →

Latest on Pathfinder Cell Therapy

Our reporting

We have not reported on Pathfinder Cell Therapy yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Pathfinder Cell Therapy's ticker?

Pathfinder Cell Therapy trades as PFND on its US listing, under ISIN US70319A1060.

What was Pathfinder Cell Therapy's last closing price?

0.00 on 30 Oct 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.